fbpx

Merck partnering with S. Korean firm to develop biosimilars

Jessica Perry//February 20, 2013

Home>News>

Merck partnering with S. Korean firm to develop biosimilars

Merck partnering with S. Korean firm to develop biosimilars

Jessica Perry//February 20, 2013

Merck & Co., in the Whitehouse Station section of Readington, announced today an agreement with Samsung Bioepis Co. Ltd. to develop and commercialize several biosimilar candidates.Under the agreement, Samsung Bioepis, of Seoul, South Korea, will be responsible for preclinical and clinical development, process development and manufacturing, clinical, trials and registration. Merck will be responsible for commercialization.

Samsung Bioepis will receive an upfront payment from Merck, product supply income and will be eligible for additional payments associated with certain clinical and regulatory milestones. Further financial terms were not disclosed.
 

d

NJBIZ Conversations

Dr. Tara Chalakani, the CEO of Preferred Behavioral Health Group, speaks with NJBIZ Editor Jeff Kanige on March 7, 2023.

NJBIZ Conversations: Tara Chalakani

Dr. Tara Chalankani, the CEO of Preferred Behavioral Health Group, talks about the problems she and her s[...]

Latest Headlines

Havemeyer Arch, Ramapo College of New Jersey

Senate holds first FY2024 NJ budget hearing in Mahwah

22/3/2023
The Vitamin Shoppe has opened a new franchise location in Valparaiso, Ind.

Vitamin Shoppe parent gets unsolicited buyout offer

22/3/2023
On March 21, Choose New Jersey announced the official opening of its new office in Tel Aviv, Israel.

Choose New Jersey opens Israel office

22/3/2023
U.S. Rep Bonnie Watson Coleman is flanked by local elected officials and BeiGene employees during a beam signing ceremony on March 21, 2023, at the Princeton West Innovation Campus in Hopewell, where the company is building a new facility that will provide state-of-the-art commercial-state U.S. biologic pharmaceutical manufacturing, late-state research and clinical development capabilities.

BeiGene reaches milestone at $700M Hopewell facility

22/3/2023
Phase 1 upgrades at Cambridge Rehabilitation & Healthcare Center in Moorestown included a 4,000-square-foot therapy gym.

Cambridge Rehabilitation completes Phase 1 upgrades

21/3/2023